Screening for Hypertensive Disorders of Pregnancy: US Preventive Services Task Force Final Recommendation Statement

Michael J. Barry; Wanda K. Nicholson; Michael Silverstein; Michael D. Cabana; David Chelmow; Tumaini Rucker Coker; Esa M. Davis; Katrina E. Donahue; Carlos Roberto Jaén; Li Li; Gbenga Ogedegbe; Goutham Rao; John M. Ruiz; James Stevermer; Joel Tsevat; Sandra Millon Underwood; John B. Wong

doi:10.1001/jama.2023.16991

Screening for Hypertensive Disorders of Pregnancy: US Preventive Services Task Force Final Recommendation Statement

Michael J. Barry, Wanda K. Nicholson, Michael Silverstein, Michael D. Cabana, David Chelmow, Tumaini Rucker Coker, Esa M. Davis, Katrina E. Donahue, Carlos Roberto Jaén, Li Li, Gbenga Ogedegbe, Goutham Rao, John M. Ruiz, James Stevermer, Joel Tsevat, Sandra Millon Underwood, John B. Wong

Pediatrics

Research output: Contribution to journal › Review article › peer-review

7 Scopus citations

Abstract

Importance: Hypertensive disorders of pregnancy are among the leading causes of maternal morbidity and mortality in the US. The rate of hypertensive disorders of pregnancy has been increasing from approximately 500 cases per 10000 deliveries in 1993 to 1021 cases per 10000 deliveries in 2016 to 2017. Objective: The US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the benefits and harms of screening for hypertensive disorders of pregnancy. Population: Pregnant persons without a known diagnosis of a hypertensive disorder of pregnancy or chronic hypertension. Evidence Assessment: The USPSTF concludes with moderate certainty that screening for hypertensive disorders in pregnancy with blood pressure measurements has substantial net benefit. Recommendation: The USPSTF recommends screening for hypertensive disorders in pregnant persons with blood pressure measurements throughout pregnancy. (B recommendation).

Original language	English (US)
Pages (from-to)	1074-1082
Number of pages	9
Journal	JAMA - Journal of the American Medical Association
Volume	330
Issue number	11
DOIs	https://doi.org/10.1001/jama.2023.16991
State	Published - Sep 19 2023

ASJC Scopus subject areas

General Medicine

Access to Document

10.1001/jama.2023.16991

Cite this

Barry, M. J., Nicholson, W. K., Silverstein, M., Cabana, M. D., Chelmow, D., Coker, T. R., Davis, E. M., Donahue, K. E., Jaén, C. R., Li, L., Ogedegbe, G., Rao, G., Ruiz, J. M., Stevermer, J., Tsevat, J., Underwood, S. M., & Wong, J. B. (2023). Screening for Hypertensive Disorders of Pregnancy: US Preventive Services Task Force Final Recommendation Statement. JAMA - Journal of the American Medical Association, 330(11), 1074-1082. https://doi.org/10.1001/jama.2023.16991

Barry, MJ, Nicholson, WK, Silverstein, M, Cabana, MD, Chelmow, D, Coker, TR, Davis, EM, Donahue, KE, Jaén, CR, Li, L, Ogedegbe, G, Rao, G, Ruiz, JM, Stevermer, J, Tsevat, J, Underwood, SM & Wong, JB 2023, 'Screening for Hypertensive Disorders of Pregnancy: US Preventive Services Task Force Final Recommendation Statement', JAMA - Journal of the American Medical Association, vol. 330, no. 11, pp. 1074-1082. https://doi.org/10.1001/jama.2023.16991

@article{462c6d145efe4122a1fbfad32b10148e,

title = "Screening for Hypertensive Disorders of Pregnancy: US Preventive Services Task Force Final Recommendation Statement",

abstract = "Importance: Hypertensive disorders of pregnancy are among the leading causes of maternal morbidity and mortality in the US. The rate of hypertensive disorders of pregnancy has been increasing from approximately 500 cases per 10000 deliveries in 1993 to 1021 cases per 10000 deliveries in 2016 to 2017. Objective: The US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the benefits and harms of screening for hypertensive disorders of pregnancy. Population: Pregnant persons without a known diagnosis of a hypertensive disorder of pregnancy or chronic hypertension. Evidence Assessment: The USPSTF concludes with moderate certainty that screening for hypertensive disorders in pregnancy with blood pressure measurements has substantial net benefit. Recommendation: The USPSTF recommends screening for hypertensive disorders in pregnant persons with blood pressure measurements throughout pregnancy. (B recommendation).",

author = "Barry, {Michael J.} and Nicholson, {Wanda K.} and Michael Silverstein and Cabana, {Michael D.} and David Chelmow and Coker, {Tumaini Rucker} and Davis, {Esa M.} and Donahue, {Katrina E.} and Ja{\'e}n, {Carlos Roberto} and Li Li and Gbenga Ogedegbe and Goutham Rao and Ruiz, {John M.} and James Stevermer and Joel Tsevat and Underwood, {Sandra Millon} and Wong, {John B.}",

year = "2023",

month = sep,

day = "19",

doi = "10.1001/jama.2023.16991",

language = "English (US)",

volume = "330",

pages = "1074--1082",

journal = "JAMA - Journal of the American Medical Association",

issn = "0098-7484",

publisher = "American Medical Association",

number = "11",

}

TY - JOUR

T1 - Screening for Hypertensive Disorders of Pregnancy

T2 - US Preventive Services Task Force Final Recommendation Statement

AU - Barry, Michael J.

AU - Nicholson, Wanda K.

AU - Silverstein, Michael

AU - Cabana, Michael D.

AU - Chelmow, David

AU - Coker, Tumaini Rucker

AU - Davis, Esa M.

AU - Donahue, Katrina E.

AU - Jaén, Carlos Roberto

AU - Li, Li

AU - Ogedegbe, Gbenga

AU - Rao, Goutham

AU - Ruiz, John M.

AU - Stevermer, James

AU - Tsevat, Joel

AU - Underwood, Sandra Millon

AU - Wong, John B.

PY - 2023/9/19

Y1 - 2023/9/19

N2 - Importance: Hypertensive disorders of pregnancy are among the leading causes of maternal morbidity and mortality in the US. The rate of hypertensive disorders of pregnancy has been increasing from approximately 500 cases per 10000 deliveries in 1993 to 1021 cases per 10000 deliveries in 2016 to 2017. Objective: The US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the benefits and harms of screening for hypertensive disorders of pregnancy. Population: Pregnant persons without a known diagnosis of a hypertensive disorder of pregnancy or chronic hypertension. Evidence Assessment: The USPSTF concludes with moderate certainty that screening for hypertensive disorders in pregnancy with blood pressure measurements has substantial net benefit. Recommendation: The USPSTF recommends screening for hypertensive disorders in pregnant persons with blood pressure measurements throughout pregnancy. (B recommendation).

AB - Importance: Hypertensive disorders of pregnancy are among the leading causes of maternal morbidity and mortality in the US. The rate of hypertensive disorders of pregnancy has been increasing from approximately 500 cases per 10000 deliveries in 1993 to 1021 cases per 10000 deliveries in 2016 to 2017. Objective: The US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the benefits and harms of screening for hypertensive disorders of pregnancy. Population: Pregnant persons without a known diagnosis of a hypertensive disorder of pregnancy or chronic hypertension. Evidence Assessment: The USPSTF concludes with moderate certainty that screening for hypertensive disorders in pregnancy with blood pressure measurements has substantial net benefit. Recommendation: The USPSTF recommends screening for hypertensive disorders in pregnant persons with blood pressure measurements throughout pregnancy. (B recommendation).

UR - http://www.scopus.com/inward/record.url?scp=85171495463&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85171495463&partnerID=8YFLogxK

U2 - 10.1001/jama.2023.16991

DO - 10.1001/jama.2023.16991

M3 - Review article

C2 - 37721605

AN - SCOPUS:85171495463

SN - 0098-7484

VL - 330

SP - 1074

EP - 1082

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

IS - 11

ER -

Screening for Hypertensive Disorders of Pregnancy: US Preventive Services Task Force Final Recommendation Statement

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this